FDA Issues Draft Guidance To Encourage Cannabis-Related Clinical Research

DISTRICT OF COLUMBIA:  The following quote is attributed to FDA Principal Deputy Commissioner Amy Abernethy M.D., Ph.D.: “A range of stakeholders have expressed interest in development of drugs that contain cannabis and compounds found in cannabis. Recent legislative changes have also opened new opportunities for cannabis clinical research. As that body of research progresses and Read the full article...